Company intelligence / Profile preview

PlantForm Corporation

Toronto, Ontario, Canadaplantformcorp.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

PlantForm has developed a proprietary plant-based expression platform, vivoXPRESS®, which enables rapid, low-cost production of monoclonal antibodies and therapeutic proteins. Their technology can reduce manufacturing costs by up to 90% compared to traditional systems and cut development timelines to as little as six weeks. The company’s pipeline includes programs in cancer, infectious diseases such as HIV/AIDS and Ebola, anti-toxins like anti-ricin antibodies, and diagnostic reagents for avian influenza. Some biosimilar candidates have shown equivalence with reference products in preclinical studies.

Therapeutic areas
OncologyInfectious Diseases
Modalities
Monoclonal antibodies (mAbs)Therapeutic proteinsVaccines
Industry
Biotech
02

Drug pipeline

3 assets

PlantForm PEDv vaccine

Preclinical

2 more assets in the full pipeline.

03

Partnerships

Defence Research and Development CanadaU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)Bill & Melinda Gates FoundationSmart BiotechAntoXa/SwiFTPharma collaborations on anti-toxin technologies.

Beyond the preview

Go deeper on PlantForm Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PlantForm Corporation.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call